Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy

Overview of attention for article published in Journal of Hematology & Oncology, August 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 28,603 followers.

#Cy #JHematolOncol Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy. https://t.co/anrX7v8o89

RT @DrMiguelPerales: Predominant cerebral cytokine release syndrome in CD19-CART therapy - He Huang #leusm #ImmunoOnc…

RT @DrMiguelPerales: Predominant cerebral cytokine release syndrome in CD19-CART therapy - He Huang #leusm #ImmunoOnc…

RT @DrMiguelPerales: Predominant cerebral cytokine release syndrome in CD19-CART therapy - He Huang #leusm #ImmunoOnc…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.